Rhumbline Advisers »

Fulcrum Therapeutics shares owned by Rhumbline Advisers

Quarter-by-quarter ownership of Fulcrum Therapeutics (FULC) shares owned by Rhumbline Advisers from 13F filings

Historical chart of Rhumbline Advisers investment in Fulcrum Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Fulcrum Therapeutics held by Rhumbline Advisers consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Fulcrum Therapeutics by Rhumbline Advisers

Quarter filed Position value Share count Share price at filing
2024-12-31 $416k 89k 4.70
2024-09-30 $311k 87k 3.57
2024-06-30 $567k 91k 6.20
2024-03-31 $16k 1.7k 9.44
2023-12-31 $11k 1.7k 6.75
2023-09-30 $7.4k 1.7k 4.44
2023-06-30 $16k 4.8k 3.30
2023-03-31 $215k 76k 2.85
2022-12-31 $435k 60k 7.28
2022-09-30 $410k 51k 8.08
2022-06-30 $233k 48k 4.90
2022-03-31 $807k 34k 23.66
2021-12-31 $561k 32k 17.69
2021-09-30 $852k 30k 28.21
2021-06-30 $236k 23k 10.50
2021-03-31 $146k 12k 11.82
2020-12-31 $139k 12k 11.72
2020-09-30 $84k 11k 7.91
2020-06-30 $233k 13k 18.31